@article{1525091caac84fd5bde3d14eadc9607b,
title = "Association Between Polyp Detection Rate and Post-Colonoscopy Cancer Among Patients Undergoing Diagnostic Colonoscopy",
abstract = "Postcolonoscopy colorectal cancer (PCCRC) can arise from missed cancers, missed premalignant lesions, incomplete resection, and new cancers with an accelerated route to cancer.1",
author = "Rachel Gingold-Belfer and Doron Boltin and Orly Sneh-Arbib and Doron Comaneshter and Arnon Cohen and Anath Flugelman and Alex Vilkin and Yaron Niv and Keinan, {Lital Boker} and Iris Dotan and Zohar Levi",
note = "Funding Information: Conflicts of interest These authors disclose the following: Arnon Cohen received research grants from Janssen, Novartis, AbbVie, Janssen, and Sanofi and served as a consultant, advisor, or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Samsung Bioepis, Sanofi, Sirbal, and Taro. Iris Dotan served as a consultant for AbbVie, Janssen, Takeda, Pfizer, Genentech/Roche, Gilead, Rafa, Celltrion, Ferring, and Medtronic and as a speaker for AbbVie, Janssen, Takeda, Pfizer, Genentech/Roche, Ferring, and Falk Pharma. The remaining authors disclose no conflicts. Publisher Copyright: {\textcopyright} 2021 AGA Institute",
year = "2021",
month = jan,
day = "1",
doi = "10.1016/j.cgh.2019.11.016",
language = "English",
volume = "19",
pages = "202--204",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "1",
}